GlobeImmune Inc (OTCMKTS:GBIM)’s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.11 and traded as low as $0.10. GlobeImmune shares last traded at $0.10, with a volume of 5,400 shares changing hands.
The firm’s 50 day moving average is $0.11.
GlobeImmune Company Profile (OTCMKTS:GBIM)
GlobeImmune, Inc, a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy.
Recommended Story: Outstanding Shares
Receive News & Ratings for GlobeImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobeImmune and related companies with MarketBeat.com's FREE daily email newsletter.